Monthly Archives: April 2019

Corpus Christi TX Health Insurance Agent Quote Comparison Service Announced

Insurance4Dallas has announced that it can help local residents around Corpus Christi, TX, to save money on their life insurance. It uses a unique quote comparison engine to allow users to compare deals and find the best option for their needs.

Corpus Christi, United States – April 26, 2019 /PressCable/

Insurance4Dallas has announced it can help local residents around Corpus Christi, TX with all their health insurance needs. As an online source of health insurance for individuals, families and small businesses, it streamlines the selection process by providing all the necessary information in an easy to read way.

More information can be found at: http://insurance4dallas.com/corpus-christi-health-insurance

The site explains that Insurance4Dallas allows visitors to compare, analyze and research a wide range of health insurance packages. It allows allows for the purchase of the right package once the visitor has made up their mind.

One of the benefits of using the Insurance4Dallas site is that it has developed partnerships with a wide variety of insurance carriers. This allows them to offer a competitive range of products online, making it easier for find the right insurance to suit their needs.

The site was launched by Rick Thornton, who has worked in the insurance field since 1986. The focus of the business is on customer satisfaction, and the site aims to be the number one online source of life and health insurance.

For local residents around Corpus Christi, Texas, the site can provide individual health insurance, pre-existing plans, small group packages, life insurance, dental insurance, Medicare and supplements, and travel insurance.

The primary goal of the site is to ensure that visitors can reduce the cost of their insurance packages by shopping and comparing plans with ease. The company’s unique quoting software allows users to enter demographic information and receive quotes from all major carriers in their area.

It’s easy to begin the process, with visitors simply having to enter their information in the box provided and enter provide their zip code.

Insurance4Dallas states: “Insurance4Dallas.com provides consumers with detailed information and the ability to apply 100% online. I4D provides a full spectrum of health, life and dental insurance plans with a selection of price and benefit options, complemented by personable customer service.”

Full details of the services available can be found on the URL above. Additional information is available at: http://insurance4dallas.com/corpus-christi-health-insurance-agent

Interested parties can get in touch at: Insurance4Dallas, 14493 S. Padre Island Dr., Suite A #5017, Corpus Christi, TX 78418 or phone (512) 410-4535

Contact Info:
Name: Rick Thornton
Email: Send Email
Organization: Insurance4Dallas
Address: 14493 South Padre Island Drive Suite A #5017, Corpus Christi, Texas 78418, United States
Phone: +1-512-410-4535
Website: http://insurance4dallas.com/corpus-christi-health-insurance/

Source: PressCable

Release ID: 506920

Cannabidiol (CBD) Global Market Demand, Growth, Opportunities, Top Key Players, Segmentation and Forecast to 2025

WiseGuyRerports.com Presents “Global Cannabidiol (CBD) Market Insights, Forecast to 2025” New Document to its Studies Database

Pune, India – April 26, 2019 /MarketersMedia/

Global Cannabidiol (CBD) market size will increase to Million US$ by 2025, from Million US$ in 2017, at a CAGR of during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Cannabidiol (CBD).

This report researches the worldwide Cannabidiol (CBD) market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. 
This study categorizes the global Cannabidiol (CBD) breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter’s Five Forces Analysis.

This report focuses on the top manufacturers’ Cannabidiol (CBD) capacity, production, value, price and market share of Cannabidiol (CBD) in global market. The following manufacturers are covered in this report: 
ENDOCA 
CBD American Shaman 
Gaia Botanicals 
Isodiol 
Medical Marijuana 
Aurora Cannabis (AC) 
Cannoid 
Canopy Growth Corporation 
CV Sciences 
IRIE CBD 
Elixinol 
NuLeaf Naturals 
PharmaHemp 
Folium Biosciences

 

 Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/3451277-global-cannabidiol-cbd-market-insights-forecast-to-2025                        

                                     

Cannabidiol (CBD) Breakdown Data by Type 
Food Grade 
Pharmaceutical Grade 
Cannabidiol (CBD) Breakdown Data by Application 
Anxiety 
Fibromyalgia (FM) 
Diabetes 
Other

Cannabidiol (CBD) Production Breakdown Data by Region 
United States 
Europe 
China 
Japan 
Other Regions

Cannabidiol (CBD) Consumption Breakdown Data by Region 
North America 
United States 
Canada 
Mexico 
Asia-Pacific 
China 
India 
Japan 

The study objectives are: 
To analyze and research the global Cannabidiol (CBD) capacity, production, value, consumption, status and forecast; 
To focus on the key Cannabidiol (CBD) manufacturers and study the capacity, production, value, market share and development plans in next few years. 
To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis. 
To define, describe and forecast the market by type, application and region. 
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. 
To identify significant trends and factors driving or inhibiting the market growth. 
To analyze the opportunities in the market for stakeholders by identifying the high growth segments. 
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market. 
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. 
To strategically profile the key players and comprehensively analyze their growth strategies.

 

Complete Report Details @ https://www.wiseguyreports.com/reports/3451277-global-cannabidiol-cbd-market-insights-forecast-to-2025                

Table Of Contents:      

1 Study Coverage 
1.1 Cannabidiol (CBD) Product 
1.2 Key Market Segments in This Study 
1.3 Key Manufacturers Covered 
1.4 Market by Type 
1.4.1 Global Cannabidiol (CBD) Market Size Growth Rate by Type 
1.4.2 Food Grade 
1.4.3 Pharmaceutical Grade 
1.5 Market by Application 
1.5.1 Global Cannabidiol (CBD) Market Size Growth Rate by Application 
1.5.2 Anxiety 
1.5.3 Fibromyalgia (FM) 
1.5.4 Diabetes 
1.5.5 Other 
1.6 Study Objectives 
1.7 Years Considered

2 Executive Summary 
2.1 Global Cannabidiol (CBD) Production 
2.1.1 Global Cannabidiol (CBD) Revenue 2013-2025 
2.1.2 Global Cannabidiol (CBD) Production 2013-2025 
2.1.3 Global Cannabidiol (CBD) Capacity 2013-2025 
2.1.4 Global Cannabidiol (CBD) Marketing Pricing and Trends 
2.2 Cannabidiol (CBD) Growth Rate (CAGR) 2018-2025 
2.3 Analysis of Competitive Landscape 
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 
2.3.2 Key Cannabidiol (CBD) Manufacturers 
2.4 Market Drivers, Trends and Issues 
2.5 Macroscopic Indicator 
2.5.1 GDP for Major Regions 
2.5.2 Price of Raw Materials in Dollars: Evolution

8 Manufacturers Profiles 
8.1 ENDOCA 
8.1.1 ENDOCA Company Details 
8.1.2 Company Description 
8.1.3 Capacity, Production and Value of Cannabidiol (CBD) 
8.1.4 Cannabidiol (CBD) Product Description 
8.1.5 SWOT Analysis 
8.2 CBD American Shaman 
8.2.1 CBD American Shaman Company Details 
8.2.2 Company Description 
8.2.3 Capacity, Production and Value of Cannabidiol (CBD) 
8.2.4 Cannabidiol (CBD) Product Description 
8.2.5 SWOT Analysis 
8.3 Gaia Botanicals 
8.3.1 Gaia Botanicals Company Details 
8.3.2 Company Description 
8.3.3 Capacity, Production and Value of Cannabidiol (CBD) 
8.3.4 Cannabidiol (CBD) Product Description 
8.3.5 SWOT Analysis 
8.4 Isodiol 
8.4.1 Isodiol Company Details 
8.4.2 Company Description 
8.4.3 Capacity, Production and Value of Cannabidiol (CBD) 
8.4.4 Cannabidiol (CBD) Product Description 
8.4.5 SWOT Analysis 
8.5 Medical Marijuana 
8.5.1 Medical Marijuana Company Details 
8.5.2 Company Description 
8.5.3 Capacity, Production and Value of Cannabidiol (CBD) 
8.5.4 Cannabidiol (CBD) Product Description 
8.5.5 SWOT Analysis 

 Continued…….                                                     

Contact Info:
Name: Norah Trent
Email: Send Email
Organization: Wiseguyreports
Address: Office No. 528/524, Amanora Chambers, Magarpatta Road, Hadapsar Pune, Maharashtra 411028
Phone: +1 (339) 368 6938 (US) +44 208 133 9349 (UK)
Website: https://www.wiseguyreports.com

Source URL: https://marketersmedia.com/cannabidiol-cbd-global-market-demand-growth-opportunities-top-key-players-segmentation-and-forecast-to-2025/506958

Source: MarketersMedia

Release ID: 506958

Web Hosting Service Market 2019 Global Key Players, Size, Applications & Growth Opportunities – Analysis to 2025

Wiseguyreports.Com Publish New Market Research Report On -“Web Hosting Service Market – Global Analysis, Size, Share, Trends, Growth and Forecast 2019 – 2025”

Pune, India – April 26, 2019 /MarketersMedia/

Web Hosting Service Market 2019

This report focuses on the global Web Hosting Service status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Web Hosting Service development in United States, Europe and China.

In 2017, the global Web Hosting Service market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.

The key players covered in this study
HostGator
1&1
InMotion
GoDaddy
DreamHost
Bluehost
Hostwinds
Liquid Web
A2 Hosting
Arvixe

Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/3344734-global-web-hosting-service-market-size-status-and-forecast-2018-2025

Market segment by Type, the product can be split into
VPS (Virtual Private Server) Web Hosting
Shared Web Hosting
Dedicated Web Hosting
Other

Market segment by Application, split into
Small & Medium-Sized Enterprises
Personal Use

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Web Hosting Service status, future forecast, growth opportunity, key market and key players.
To present the Web Hosting Service development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

Complete Report Details @ https://www.wiseguyreports.com/reports/3344734-global-web-hosting-service-market-size-status-and-forecast-2018-2025

Table of Contents –Analysis of Key Points

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Web Hosting Service Market Size Growth Rate by Type (2013-2025)
1.4.2 VPS (Virtual Private Server) Web Hosting
1.4.3 Shared Web Hosting
1.4.4 Dedicated Web Hosting
1.4.5 Other
1.5 Market by Application
1.5.1 Global Web Hosting Service Market Share by Application (2013-2025)
1.5.2 Small & Medium-Sized Enterprises
1.5.3 Personal Use
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Web Hosting Service Market Size
2.2 Web Hosting Service Growth Trends by Regions
2.2.1 Web Hosting Service Market Size by Regions (2013-2025)
2.2.2 Web Hosting Service Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Web Hosting Service Market Size by Manufacturers
3.1.1 Global Web Hosting Service Revenue by Manufacturers (2013-2018)
3.1.2 Global Web Hosting Service Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Web Hosting Service Market Concentration Ratio (CR5 and HHI)
3.2 Web Hosting Service Key Players Head office and Area Served
3.3 Key Players Web Hosting Service Product/Solution/Service
3.4 Date of Enter into Web Hosting Service Market
3.5 Mergers & Acquisitions, Expansion Plans

……….

12 International Players Profiles
12.1 HostGator
12.1.1 HostGator Company Details
12.1.2 Company Description and Business Overview
12.1.3 Web Hosting Service Introduction
12.1.4 HostGator Revenue in Web Hosting Service Business (2013-2018)
12.1.5 HostGator Recent Development
12.2 1&1
12.2.1 1&1 Company Details
12.2.2 Company Description and Business Overview
12.2.3 Web Hosting Service Introduction
12.2.4 1&1 Revenue in Web Hosting Service Business (2013-2018)
12.2.5 1&1 Recent Development
12.3 InMotion
12.3.1 InMotion Company Details
12.3.2 Company Description and Business Overview
12.3.3 Web Hosting Service Introduction
12.3.4 InMotion Revenue in Web Hosting Service Business (2013-2018)
12.3.5 InMotion Recent Development
12.4 GoDaddy
12.4.1 GoDaddy Company Details
12.4.2 Company Description and Business Overview
12.4.3 Web Hosting Service Introduction
12.4.4 GoDaddy Revenue in Web Hosting Service Business (2013-2018)
12.4.5 GoDaddy Recent Development
12.5 DreamHost
12.5.1 DreamHost Company Details
12.5.2 Company Description and Business Overview
12.5.3 Web Hosting Service Introduction
12.5.4 DreamHost Revenue in Web Hosting Service Business (2013-2018)
12.5.5 DreamHost Recent Development
12.6 Bluehost
12.6.1 Bluehost Company Details
12.6.2 Company Description and Business Overview
12.6.3 Web Hosting Service Introduction
12.6.4 Bluehost Revenue in Web Hosting Service Business (2013-2018)
12.6.5 Bluehost Recent Development
12.7 Hostwinds
12.7.1 Hostwinds Company Details
12.7.2 Company Description and Business Overview
12.7.3 Web Hosting Service Introduction
12.7.4 Hostwinds Revenue in Web Hosting Service Business (2013-2018)
12.7.5 Hostwinds Recent Development
12.8 Liquid Web
12.8.1 Liquid Web Company Details
12.8.2 Company Description and Business Overview
12.8.3 Web Hosting Service Introduction
12.8.4 Liquid Web Revenue in Web Hosting Service Business (2013-2018)
12.8.5 Liquid Web Recent Development
12.9 A2 Hosting
12.9.1 A2 Hosting Company Details
12.9.2 Company Description and Business Overview
12.9.3 Web Hosting Service Introduction
12.9.4 A2 Hosting Revenue in Web Hosting Service Business (2013-2018)
12.9.5 A2 Hosting Recent Development
12.10 Arvixe
12.10.1 Arvixe Company Details
12.10.2 Company Description and Business Overview
12.10.3 Web Hosting Service Introduction
12.10.4 Arvixe Revenue in Web Hosting Service Business (2013-2018)
12.10.5 Arvixe Recent Development

Continued…..

Contact Info:
Name: Norah Trent
Email: Send Email
Organization: WISE GUY RESEARCH CONSULTANTS PVT LTD
Address: Office No.528,Amanora Chambers,Magarpatta Road,Hadapsar,Pune-411028.
Phone: +1-646-845-9349
Website: https://www.wiseguyreports.com

Source URL: https://marketersmedia.com/web-hosting-service-market-2019-global-key-players-size-applications-growth-opportunities-analysis-to-2025/505834

Source: MarketersMedia

Release ID: 505834

Market for Radiology Information Systems (RIS) Industry 2019 examined in latest research report

The Global Radiology Information Systems (RIS) Industry Research Report includes companies engaged in manufacturing, capacity, production, price, cost, revenue and contact information.

Dublin, United States – April 26, 2019 /MarketersMedia/

The report provides information about Radiology Information Systems (RIS) Market by types like Cloud Based, Install Based, combined by applications Hospitals, Office Based Physicians, Emergency Healthcare Service Providers, Other.  Key Players in the report are Paxeramed Corp, Infinitt North America Inc, CoActiv Medical, Merge Healthcare Inc & More.

 

This report studies the global Radiology Information Systems (RIS) market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global RADIOLOGY INFORMATION SYSTEMS (RIS) market by companies, region, type and end-use industry.

 

REQUEST FOR SAMPLE PDF AT

https://inforgrowth.com/sample-request/1876317/ris-radiology-information-systems-market

 

This report focuses on the Global Top Players including Paxeramed Corp, Infinitt North America Inc, CoActiv Medical, Merge Healthcare Inc, Global Imaging On Line, Advanced Data Systems Corporation, AGFA Healthcare, IMAGE Information Systems Ltd, Birlamedisoft, Infinitt Healthcare, Medigration, RamSoft, Spintech Oceania, Nexus AG, Carestream, Novarad, Cerner

 

THE STUDY OBJECTIVES OF THIS REPORT ARE:

To analyze and research the Radiology Information Systems (RIS) status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Radiology Information Systems (RIS) manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

FOR MORE CUSTOMIZATION ON THIS REPORT AT

https://inforgrowth.com/customization/1876317/ris-radiology-information-systems-market

 

TABLE OF CONTENTS INCLUDE

Global Radiology Information Systems (RIS) Competition Analysis by Players, Global Radiology Information Systems (RIS) Market Size by Type and Application (2013-2018), Industry Overview of Radiology Information Systems (RIS), Market Effect Factors Analysis, Market Forecast by Regions, Type and Application (2018-2025) 

 

SOME OF THE KEY TABLES IN THE REPORT INCLUDE:

Table Global Radiology Information Systems (RIS) Market Size of Key Regions (Million USD) & (K Units)
Table Global Radiology Information Systems (RIS) Growth Rate of Key Regions 2019-2025 (Million USD)
Table Global Radiology Information Systems (RIS) Market Share for of Regions 2019-2025 (K Units)
Table Market Top Trends
Table Global Radiology Information Systems (RIS) Capacity by Manufacturers (2014-2019) (K Units)
Table Global Radiology Information Systems (RIS) Capacity Market Share by Manufacturers (2014-2019)
Table Global Radiology Information Systems (RIS) Production by Manufacturers (2014-2019) (K Units)
Table Global Radiology Information Systems (RIS) Production Share by Manufacturers (2014-2019)
Table Radiology Information Systems (RIS) Revenue by Manufacturers (2014-2019) (Million USD)
Table Radiology Information Systems (RIS) Revenue Share by Manufacturers (2014-2019)

ASK YOUR QUERIES ABOUT RADIOLOGY INFORMATION SYSTEMS (RIS) MARKET

https://inforgrowth.com/enquiry/1876317/ris-radiology-information-systems-market

ABOUT INFORGROWTH:
We are a market-intelligence company formed with the objective of providing clients access to the most relevant and accurate research content for their growth needs. At InForGrowth, we understand Research requirements and help a client in taking informed business-critical decisions. Given the complexities and interdependencies of market-intelligence, there is always more than one source to explore and arrive at the right answer. Through our smart search feature and our reliable & trusted publishing partners, we are paving way for more simplified and relevant research.

Contact Info:
Name: Rohan
Email: Send Email
Organization: InForGrowth
Address: 6400 VILLAGE PKWY SUITE # 104,
Phone: 9093292808
Website: https://www.inforgrowth.com

Source URL: https://marketersmedia.com/market-for-radiology-information-systems-ris-industry-2019-examined-in-latest-research-report/506965

Source: MarketersMedia

Release ID: 506965

Angle PLC Announces Immune Suppressor Cells Promote Metastasis

BREAKTHROUGH RESEARCH
USING THE PARSORTIX SYSTEM DISCOVERS ROLE OF BODY’S OWN IMMUNE SUPPRESSOR CELLS
IN PROMOTING CANCER METASTASIS

Research using Parsortix
discovers large CTC clusters of 10-30 cells comprising both cancer cells and
immune suppressor cells, which dramatically increase cancer metastasis

Parsortix system offers
key capabilities for research into CTC clusters to target new ways to disable
the cancer-promoting role of immune suppressor cells

GUILDFORD, SURREY / ACCESSWIRE / April 26, 2019 / ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, is delighted to announce that its ParsortixTM system has been utilised in further groundbreaking new cancer research which demonstrates for the first time the role of myeloid-derived suppressor cells (MDSCs) as part of large circulating tumor cell (CTC) clusters, which are 50x more likely to generate metastasis than single CTCs.

The research, led by Professor Dario Marchetti at the Biomarker Research Program, Houston Methodist Research Institute (Houston, Texas, United States) in conjunction with the Center for Precision Health, University of Texas and MD Anderson Cancer Center has been published as a peer-reviewed publication in the International Journal of Molecular Sciences.

The research investigated metastatic breast and melanoma cancers and found that the Parsortix system harvested large CTC clusters comprising 10-30 cells in 100% of the patient samples (n=33). In contrast, a leading antibody CTC system was unable to capture large CTC clusters in any samples and only identified small CTC clusters comprising 2-3 cells in less than 50% of the samples.

The research work investigated for the first time the role of MDSCs in CTC clusters. MDSCs are a subset of the body’s immune cells, which are distinct from neutrophils which have been separately studied by other ANGLE customers, and provide the body with a sophisticated mechanism to balance an extensive immune response to protect from excessive tissue damage and autoimmune disorders. MDSCs interact with other immune cell types including T cells, dendritic cells, macrophages and natural killer cells to regulate their functions. Unfortunately cancer cells can take an advantage of those immunosuppressive mechanisms to protect themselves against the body’s anti-cancer immune responses.

Investigation of the role of MDSCs in CTC clusters is seminal work because, instead of assisting the patient’s immune system to combat the cancer, the MDSCs actually play a number of key roles in promoting cancer metastasis by:

• suppressing the body’s immune response to the cancer

• enhancing CTC survival and proliferation

• increasing CTC metastatic potency and dissemination.

The research work investigated each of these factors. A key finding was that, when CTCs were cultured, the addition of MDSCs lead to an increase in the number of CTCs by a factor of 10 compared to a control CTC culture without the addition.

The development of metastasis, the spread of cancer to distant sites primarily via the blood, is responsible for more than 90% of all cancer-related deaths. If metastasis could be suppressed by disrupting the role of the MDSCs in the CTC clusters then patient outcomes could be dramatically improved.

ANGLE’s Parsortix system has again been shown to have key advantages in harvesting CTC clusters, expanding the potential use of the Parsortix system in the growing CTC cluster research field with the prospect of routine use as a companion diagnostic for immunotherapy and other drugs to disrupt CTC clusters.

Professor Dario Marchetti at the Biomarker Research Program,
Houston Methodist Research Institute, Houston, Texas, United States, commented:

“This study is the first to demonstrate the detection and functionality of naïve, heterotypic clusters consisting of CTCs and circulatory MDSCs directly isolated from the peripheral blood of metastatic cancer patients. This opens up a whole new area of research with the prospect of stabilizing cancer progression to reduce its spread or metastasis. The Parsortix state-of-the-art technology platform played a key role in enabling us to directly capture/isolate heterotypic CTC clusters from patients’ blood for downstream interrogation.”

ANGLE Founder and Chief Executive, Andrew Newland, commented:

“Investigation into CTC clusters and their impact on metastasis, an area where ANGLE’s Parsortix system is strongly differentiated, is beginning to take off with further seminal work by another one of ANGLE’s leading customers. This work identifies the role of immune suppressor cells within the CTC cluster highlighting key new areas for drug development with the potential for Parsortix to be routinely used as a companion diagnostic. Our ultimate aim is for the Parsortix system to be routinely used for all cancer patients in the future.”

The study published in the International Journal of Molecular Sciences can be accessed here:https://angleplc.com/library/publications/

For further information ANGLE:

ANGLE plc

+44 (0) 1483 343434

Andrew Newland, Chief Executive

Ian Griffiths, Finance Director

finnCap Ltd (NOMAD and Joint Broker)

Corporate Finance – Carl Holmes, Simon Hicks, Max Bullen-Smith

ECM – Alice Lane / Sunila da Silva

+44 (0)20 7220 0500

WG Partners (Joint Broker)

Nigel Barnes, Nigel Birks, Andrew Craig, Chris Lee

+44 (0) 203 705 9330

FTI Consulting

Simon Conway, Ciara Martin

Matthew Ventimiglia (US)

+44 (0) 203 727 1000

+1 (212) 850 5624

The information
communicated in this announcement is inside information for the purposes of
Article 7 of Regulation 596/2015.

For Frequently Used Terms, please see the Company’s website on http://www.angleplc.com/the-parsortix-system/glossary/

Notes for editors

About ANGLE plc www.angleplc.com

ANGLE is a world leading liquid biopsy company with sample-to-answer solutions. ANGLE’s proven patent protected platforms include an epitope-independent circulating tumor cell (CTC) harvesting technology and a downstream analysis system for cost effective, highly multiplexed analysis of nucleic acids and proteins.

ANGLE’s cell separation technology is called the Parsortix
TM system, and it enables a liquid biopsy (a simple blood test) to be used to provide the cells of interest to the user in a format suitable for multiple downstream subsequent analyses. CTCs enable the complete picture of a cancer to be seen as they allow DNA, RNA and protein analysis and the live cells harvested can be cultured. The Parsortix technology is the subject of 21 granted patents in Europe, the United States, Canada, India, China, Japan and Australia with three extensive families of patents are being progressed worldwide. The system is based on a microfluidic device that captures cells based on a combination of their size and compressibility. The Parsortix system has a CE Mark in Europe for the indicated use and FDA clearance is in process for the United States with a 400 subject study in metastatic breast cancer. ANGLE is seeking to be the first ever FDA cleared CTC harvesting system and only the third ever FDA cleared liquid biopsy test. ANGLE has already undertaken two separate 200 subject clinical studies under a program designed to develop an ovarian cancer pelvic mass triage test, with the results showing best in class accuracy (ROC-AUC) of 95.1%. The pelvic mass triage assay has undergone further refinement and optimisation, and is currently in the process of a clinical verification study.

ANGLE’s technology for the multiplex evaluation of proteins and nucleic acids of all types is called the HyCEADTM Ziplex® platform and is based on a patented flow through array technology. It provides for low cost, highly multiplexed, rapid and sensitive capture of targets from a wide variety of sample types. A proprietary chemistry approach (the HyCEAD method) allows for the capture and amplification of over 100 biomarkers simultaneously in a single reaction. The HyCEAD Ziplex system is ideal for measuring gene expression and other markers directly from Parsortix harvests and was used in the ovarian cancer pelvic mass triage test to achieve best in class accuracy (ROC-AUC) of 95.1%.

ANGLE’s proprietary technologies can be combined to provide automated, sample-to-answer results in both centralised laboratory and point-of-use cartridge formats.

ANGLE has established formal collaborations with world-class cancer centres and major corporates such as QIAGEN, Abbott and Philips, and works closely with leading CTC translational research customers. These Key Opinion Leaders (KOLs) are working to identify applications with medical utility (clear benefit to patients), and to secure clinical data that demonstrates that utility in patient studies. The body of evidence as to the benefits of the Parsortix system is growing rapidly from our own clinical studies in metastatic breast cancer and ovarian cancer and also from KOLs with 20 peer-reviewed publications and numerous publicly available posters, available on our website.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: ANGLE plc

ReleaseID: 543097

Valeura Energy Inc. Announces Operations Update

Drilling Success, Stimulation Programme Agreed, Focus on
Flow-Testing

CALGARY, AB / ACCESSWIRE / April 26, 2019 / Valeura Energy Inc. (TSX:VLE, LSE:VLU) (“Valeura” or the “Company”), the upstream natural gas producer focused on appraising and developing an unconventional gas accumulation in the Thrace Basin of Turkey in partnership with Equinor, is pleased to provide an operations update concerning its Basin Centered Gas Accumulation (“BCGA”) appraisal programme.

Highlights

• Devepinar-1 drilled to 4,796 metres with clear indications of over-pressured gas throughout the 1,066 metre gross column in the Teslimkoy and Kesan Formations

• Inanli-1 pressure measurements confirm the well is significantly over-pressured, and the reservoir stimulation and testing programme is expected to commence in late May

• With 11 vertical wells now demonstrating high-pressure gas around the basin, the focus for data acquisition and operations is shifting to continued stimulation and production testing of drilled wells

Sean
Guest, President and CEO Commented:

“We are
encouraged by the preliminary results we have seen from drilling and logging
Devepinar-1. The data supports our play mapping and confirms that
reservoir and over-pressured gas are present some 20 kilometres away from the
Yamalik-1 and Inanli-1 wells.

At this
stage, we have nearly a dozen wells across the basin that demonstrate the
presence of over-pressured gas and a laterally continuous objective reservoir.
This basin is almost a half million acres in size and our recent penetrations
have drilled up to a mile of continuous gross gas column. The scale of the
resource is significant, and while we have a very good understanding of the basin’s
geology and the presence of over-pressured gas, we have as yet only partially
stimulated and flow tested one exploration well, Yamalik-1. Our near-term focus
is shifting squarely to production testing multiple zones across our new wells
to understand the gas flow characteristics of our reservoir both vertically and
laterally.”

Devepinar-1

The Devepinar-1 appraisal well was drilled safely to 4,796 metres, approximately 500 metres deeper than originally planned due to significant gas shows and faster drilling penetration rates. The top of the objective reservoir was encountered at 3,730 metres and the gross 1,066 metres of the Teslimkoy and Kesan Formations is interpreted to be gas-bearing down to the total depth of the well. During drilling operations, formation gas was circulated to surface and flared several times, and much of the deep drilling operation was conducted with mud weights in excess of 0.78 psi/ft to manage gas inflow.

The well met all of its drilling objectives and most significantly, confirms the presence of over-pressured, gas-bearing reservoir at the western flank of the mapped BCGA fairway. The log data and the higher penetration rates both indicate that the porosity at Devepinar-1 is higher when compared to the Inanli-1 and Yamalik-1 wells at similar depths. These results greatly increase the Company’s understanding of the lateral extent of the reservoir and occurrence of over-pressure related to the Company’s basin-wide play mapping. The Devepinar-1 well has multiple zones of interest with the best zones of interest being located in the upper Kesan Formation, as they were in the previously drilled wells.

High-grading of potential intervals of interest is now underway, in advance of developing a reservoir stimulation programme, jointly with the Company’s partners.

The well was operated by Valeura, with costs shared proportionately based on the working interest share of each partner (Valeura 31.5%). Despite the well being drilled deeper than anticipated, drilling and logging operations were conducted below budget. The well is currently being cased and will be left in a state ready for testing and completion.

Inanli-1

The Inanli-1 completion programme commenced with a diagnostic fracture injectivity test (“DFIT”) to confirm high downhole pressures interpreted from mud weights during drilling. This is a critical step to ensure, among other things, surface equipment for the completion programme is appropriately pressure-rated to ensure safe operations. The lowest DFIT at 4,813 metres confirms a pressure gradient of 0.809 psi/ft (significant over-pressure), in line with observations made at Yamalik-1. A second extended DFIT is currently being conducted on a specific completion zone to establish formation fracture stimulation parameters and pore pressure prior to commencing reservoir stimulation operations. In accordance with the DFIT results, suitable equipment rated for up to 15,000 psi has been sourced internationally and is being imported to Turkey. The Company anticipates all equipment will be on site for the first fracture stimulation operations later in May 2019.

The overall goal of the Inanli-1 completion programme is to selectively test key intervals in the approximately 1,600 metre reservoir section and to provide definitive, longer term flow results for each interval. Given the significant vertical interval, the completion has been tailored to test the deepest naturally fractured intervals (initial zones to be completed) to the shallower sweet spots (later in the programme). The programme is designed to include up to 10 fracs in as many as five separate flow zones and will incorporate more sophisticated flow tracing and longer flow periods than the Yamalik-1 completion. In service of this longer test programme, the Company has constructed a pipeline to the location so that gas can be captured through Valeura’s local infrastructure and sold to customers.

The costs for the Inanli-1 stimulation and testing will be fully carried by Equinor and will complete their earning obligations under the Banarli farm in agreement.

Near-term
operations focus

Valeura and Equinor have now built a strong understanding of the geology of the BCGA play and the presence of over-pressured gas, based on 11 vertical well penetrations, including Yamalik-1, Inanli-1, Devepinar-1, and eight other legacy wells. The two recent wells have both demonstrated that the over-pressured gas extends down to almost 5,000 metres and that seismic data can be used to help predict natural fracturing ahead of drilling.

With a formidable body of new geologic knowledge, appraisal wells that are 20 kilometres apart, and up to a mile of vertical objective reservoir to evaluate, Valeura and Equinor believe the right next step is to focus operations on better understanding the rocks’ flow characteristics with the objective to demonstrate commercial flow rates, rather than drilling another vertical well at this time. Accordingly, the KCA Deutag drilling rig will be released. Over the coming months, the completions of the Inanli-1 and Devepinar-1 wells will provide critical data on reservoir zones at varying depths, pressures, fracture density, hydrocarbon maturities and reservoir quality. These flow data will then be used to select the next drilling locations, and to determine whether there are zones that should be considered as early horizontal development well targets.

About Valeura
Energy

Valeura Energy Inc. is a Canada-based public company engaged in the exploration, development and production of petroleum and natural gas in Turkey.

Since Valeura was established in 2010, the Company has executed a number of transactions and currently holds interests in 20 production leases and exploration licences in the Thrace Basin of Turkey totalling 0.46 MM acres (gross) or on a net basis 0.37 MM acres of shallow rights and 0.26 MM net acres of deep rights.

Valeura is appraising an unconventional basin-centered gas accumulation play in the Thrace Basin on its deep rights, whichhas been evaluated by DeGolyer and MacNaughton to hold, effective December 31, 2018, 10.1 Tcfe of estimated working interest unrisked mean prospective resources of natural gas, which includes 236 MMbbl of condensate. By applying 3D seismic, modern reservoir stimulation technology and horizontal and deeper vertical well drilling, Valeura is aiming to achieve commercial scale operations from this tight gas resource.

In addition, the Company owns an extensive network of gas gathering and sales infrastructure to support direct marketing of natural gas to end users, and in 2018, produced an average of 4.3 MMcf/d of natural gas from conventional gas accumulations in its shallower rights.

Additional information relating to Valeura is also available on SEDAR at www.sedar.com and on the Company’s corporate website at www.valeuraenergy.com.

For further information please contact:

Valeura
Energy Inc. (General and Investor Enquiries)
+1
403 237 7102

Sean Guest, President and CEO

Steve Bjornson, CFO

Robin Martin, Investor Relations Manager

Contact@valeuraenergy.com, IR@valeuraenergy.com

GMP First
Energy (Financial Adviser and Corporate
Broker) +44 (0) 20 7448 0200

Jonathan Wright, Hugh Sanderson

Canaccord
Genuity Limited (Joint Corporate
Broker)
+44 (0) 20 7523 8000

Henry Fitzgerald-O’Connor, James Asensio

CAMARCO
(Public Relations, Media
Adviser)
+44 (0) 20
3757 4980

Owen Roberts, Billy Clegg, Monique Perks, Thayson Pinedo

Valeura@camarco.co.uk

Oil and Gas
Advisories & Definitions

Prospective resources are those quantities of petroleum estimated, as of a given date, to be potentially recoverable from undiscovered accumulations by application of future development projects. Prospective resources have both an associated chance of discovery and a chance of development.

There is no certainty that any portion of the prospective resources will be discovered. If a discovery is made, there is no certainty that it will be developed or, if it is developed, there is no certainty as to the timing of such development or that it will be commercially viable to produce any portion of the prospective resources.

Please see the Company’s annual information form for the year ended December 31, 2018, which is available under Valeura’s issuer profile on SEDAR at www.sedar.com, for more information with respect to the Company’s prospective resources, including details regarding risked estimates.

Forward-Looking
Statements and Cautionary Statements

This news release contains certain forward-looking statements and information (collectively referred to herein as ”
forward-looking information”) including, but not limited to: the characteristics and objectives of the Inanli-1 completion programme; Valeura’s intent to frac and production test the Inanli-1 well; the timing to commence fracking and testing operations; that Equinor will complete their earning obligations under the Banarli farm in agreement; the assessment of the resources in the test formations; the potential of the Company’s unconventional basin-centered gas accumulation play in the Thrace Basin; and the Company’s intention to achieve commercial scale operations. Forward-looking information typically contains statements with words such as “anticipate”, estimate”, “expect”, “target”, “potential”, “could”, “should”, “would” or similar words suggesting future outcomes. The Company cautions readers and prospective investors in the Company’s securities to not place undue reliance on forward-looking information, as by its nature, it is based on current expectations regarding future events that involve a number of assumptions, inherent risks and uncertainties, which could cause actual results to differ materially from those anticipated by the Company.

Statements related to “prospective resources” are deemed forward-looking statements as they involve the implied assessment, based on certain estimates and assumptions, that the prospective resources can be profitably produced in the future. Specifically, forward-looking information contained herein regarding “prospective resources” include volumes of prospective resources and the ability to finance future development and, the conversion of a portion of prospective resources into reserves.

Forward-looking information is based on management’s current expectations and assumptions regarding, among other things: continued political stability of the areas in which the Company is operating; continued safety of operations and ability to proceed in a timely manner; continued operations of and approvals forthcoming from the Turkish government and regulators in a manner consistent with past conduct; future seismic and drilling activity on the expected timelines; the continued favourable pricing and operating netbacks in Turkey; future production rates and associated operating netbacks and cash flow; decline rates; future sources of funding; future economic conditions; future currency exchange rates; the ability to meet drilling deadlines and other requirements under licenses and leases; and the Company’s continued ability to obtain and retain qualified staff and equipment in a timely and cost efficient manner. In addition, the Company’s work programmes and budgets are in part based upon expected agreement among joint venture partners and associated exploration, development and marketing plans and anticipated costs and sales prices, which are subject to change based on, among other things, the actual results of drilling and related activity, availability of drilling, fracking and other specialised oilfield equipment and service providers, changes in partners’ plans and unexpected delays and changes in market conditions. Although the Company believes the expectations and assumptions reflected in such forward-looking information are reasonable, they may prove to be incorrect.

Forward-looking information involves significant known and unknown risks and uncertainties. Exploration, appraisal, and development of oil and natural gas reserves are speculative activities and involve a degree of risk. A number of factors could cause actual results to differ materially from those anticipated by the Company including, but not limited to: the risks of currency fluctuations; changes in gas prices and netbacks in Turkey; uncertainty regarding the contemplated timelines and costs for the deep evaluation; the risks of disruption to operations and access to worksites, threats to security and safety of personnel and potential property damage related to political issues or civil unrest in Turkey; potential changes in laws and regulations, the uncertainty regarding government and other approvals; counterparty risk; risks associated with weather delays and natural disasters; and the risk associated with international activity. The forward-looking information included in this news release is expressly qualified in its entirety by this cautionary statement. The forward-looking information included herein is made as of the date hereof and Valeura assumes no obligation to update or revise any forward-looking information to reflect new events or circumstances, except as required by law. See the AIF for a detailed discussion of the risk factors.

Additional information relating to Valeura is also available on SEDAR at www.sedar.com.

This
announcement does not constitute an offer to sell or the solicitation of an
offer to buy securities in any jurisdiction, including where such offer would
be unlawful. This announcement is not for distribution or release, directly or
indirectly, in or into the United States, Ireland, the Republic of South Africa
or Japan or any other jurisdiction in which its publication or distribution
would be unlawful.

Neither the
Toronto Stock Exchange nor its Regulation Services Provider (as that term is
defined in the policies of the Toronto Stock Exchange) accepts responsibility
for the adequacy or accuracy of this news release.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: Valeura Energy Inc.

ReleaseID: 543098

Vacation Ownership Market 2019-2023 | Global Trends Analysis Forecast by Top Manufacturers, Key Regions, And Forecast

MarketReportsOnline.com adds The US Vacation Ownership (Timeshare) Market (2019-2023 Edition) research report of 55 pages published in April 2019 to the travel & hospitality market data collection of its online business intelligence library.

Pune, India – April 26, 2019 /MarketersMedia/

This latest report titled “The US Vacation Ownership (Timeshare) Market (2019-2023 Edition)” provides an in-depth analysis of the US vacation ownership market with detailed analysis of market size on the basis of value and volume along with the comprehensive examination of each of the major segments of the market, namely, timeshare resorts and other timeshare units. A global analysis of the vacation ownership market has been included in the report in order to demonstrate the position of the US with respect to the global market.

The report provides detailed competitive landscape for the market on the basis of some important metrics across the timeshare industry, number of time share units in the US domestic markets and major transactions that occurred in the market during the period 2013-2017.

Purchase a copy of this “US Vacation Ownership (Timeshare) Market” report at USD 800 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=784622.

Growth of the overall US vacation ownership market has also been forecasted for the period 2019-2023, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

Wyndham Destinations (Formerly Wyndham Worldwide Corporation), Marriott International, Apollo Global Management (Diamond Resorts International) and Hilton Grand Vacation Company are some of the key players operating in the US vacation ownership market whose company profiling has been done in the report. In this section of the report, business overview, financial overview and business strategies have been provided.

Key Company Coverage of Vacation Ownership (timeshare) Market:
• Wyndham Destinations (Formerly Wyndham Worldwide Corporation)
• Marriott International
• Apollo Global Management (Diamond Resorts International)
• Hilton Grand Vacation Company

Request a Sample Copy of this Report at http://www.marketreportsonline.com/contacts/requestsample.php?name=784622.

The US vacation Ownership (timeshare) market witnessed an upsurge at a significant CAGR during the years spanning 2014-2018 and estimations are made that the market would rise through the forecast period 2019-2023.

The vacation ownership market is the major segment of the travel and tourism market, which can be segmented on the basis of the type of the timeshare properties into timeshare resorts and other timeshare units, which includes, privately-owned vacation homes, villas, cottages, apartments, condominiums and etc. Although, other timeshare units account the largest market share, timeshare resorts are gaining the momentum.

The major growth drivers for the US vacation ownership market are, increasing prominence of point based vacation ownerships, timeshare sales metrics, property purchasing preferences, perception, travel and tourism industry and high net worth individual population and wealth. Despite the market is governed by various growth drivers, there are certain challenges faced by the market such as, threat from third party internet travel intermediaries, seasonality, dream vacation barriers, highly competitive environment and technical issues.

Some of the recent trends in the market include the scope of virtual and augmented reality in the timeshare industry, the rise in the vacation ownership households, inventory levels and next generation of timeshare prospects.

Major Points from Table of Contents Covered in US Vacation Ownership Market 2019-2023 Edition Report:

1. Executive Summary

2. Introduction
2.1 Introduction to Vacation Ownership
2.2 Stages of Vacation Ownership Operations
2.3 Advantages of Vacation Ownership
2.4 Evolution of Vacation Ownership Market

3. Global Market Analysis
3.1 Global Vacation Ownership Market: An Analysis

4. The US Market Analysis
4.1 The US Vacation Ownership Market: Value Analysis
4.2 The US Vacation Ownership Market: Volume Analysis
4.3 The US Vacation Ownership Market by Average Occupancy
4.4 The US Vacation Ownership Market by Region

5. Market Dynamics
5.1 Growth Drivers
5.2 Challenges
5.3 Market Trends

6. Competitive Landscape
6.1 The US Vacation Ownership Market: Competitive Landscape

7. Company Profiles

Browse all latest travel & hospitality market research reports at http://www.marketreportsonline.com/cat/hospitality-market-research.html.

About Us:
Market Reports Online is a comprehensive online library of more than 100,000 reports, in-depth market research studies on thousands of micro markets and a range of industries. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe. We offer online and offline support services to ensure your research requirements are met on time.

Contact Info:
Name: Vishal Kalra
Email: Send Email
Organization: MarketReportsOnline
Phone: + 1 888 391 5441
Website: http://www.marketreportsonline.com/contacts/requestsample.php?name=784622

Source URL: https://marketersmedia.com/vacation-ownership-market-2019-2023-global-trends-analysis-forecast-by-top-manufacturers-key-regions-and-forecast/506716

Source: MarketersMedia

Release ID: 506716

Global Espresso Coffee Market 2019 Key Players, Share, Trends, Sales, Segmentation and Forecast to 2025

WiseGuyRerports.com Presents “Global Espresso Coffee Market Research Report 2018” New Document to its Studies Database

Pune, India – April 26, 2019 /MarketersMedia/

Global Espresso Coffee market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including 
Luigi Lavazza S.p.A. 
Tchibo 
Segafredo Zanetti (Massimo Zanetti Beverage Group) 
Bristot (Procaffé S.p.A) 
illy 
Co.ind s.c. 
Peet’s 
… 

 Request For Sample Report @ https://www.wiseguyreports.com/sample-request/3109255-global-espresso-coffee-market-research-report-2018                     

                                 

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into 
Online Sales 
Ofline Sales 
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including 
Home & Office 
Coffee Shop 
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 

Complete Report Details @ https://www.wiseguyreports.com/reports/3109255-global-espresso-coffee-market-research-report-2018          

Table Of Contents:                                                                                                                          

1 Espresso Coffee Market Overview 
1.1 Product Overview and Scope of Espresso Coffee 
1.2 Espresso Coffee Segment by Type (Product Category) 
1.2.1 Global Espresso Coffee Production and CAGR (%) Comparison by Type (Product Category)(2013-2025) 
1.2.2 Global Espresso Coffee Production Market Share by Type (Product Category) in 2017 
1.2.3 Online Sales 
1.2.4 Ofline Sales 
1.3 Global Espresso Coffee Segment by Application 
1.3.1 Espresso Coffee Consumption (Sales) Comparison by Application (2013-2025) 
1.3.2 Home & Office 
1.3.3 Coffee Shop 
1.3.4 Other 
1.4 Global Espresso Coffee Market by Region (2013-2025) 
1.4.1 Global Espresso Coffee Market Size (Value) and CAGR (%) Comparison by Region (2013-2025) 
1.4.2 North America Status and Prospect (2013-2025) 
1.4.3 Europe Status and Prospect (2013-2025) 
1.4.4 China Status and Prospect (2013-2025) 
1.4.5 Japan Status and Prospect (2013-2025) 
1.4.6 Southeast Asia Status and Prospect (2013-2025) 
1.4.7 India Status and Prospect (2013-2025) 
1.5 Global Market Size (Value) of Espresso Coffee (2013-2025) 
1.5.1 Global Espresso Coffee Revenue Status and Outlook (2013-2025) 
1.5.2 Global Espresso Coffee Capacity, Production Status and Outlook (2013-2025)

2 Global Espresso Coffee Market Competition by Manufacturers 
2.1 Global Espresso Coffee Capacity, Production and Share by Manufacturers (2013-2018) 
2.1.1 Global Espresso Coffee Capacity and Share by Manufacturers (2013-2018) 
2.1.2 Global Espresso Coffee Production and Share by Manufacturers (2013-2018) 
2.2 Global Espresso Coffee Revenue and Share by Manufacturers (2013-2018) 
2.3 Global Espresso Coffee Average Price by Manufacturers (2013-2018) 
2.4 Manufacturers Espresso Coffee Manufacturing Base Distribution, Sales Area and Product Type 
2.5 Espresso Coffee Market Competitive Situation and Trends 
2.5.1 Espresso Coffee Market Concentration Rate 
2.5.2 Espresso Coffee Market Share of Top 3 and Top 5 Manufacturers 
2.5.3 Mergers & Acquisitions, Expansion

…..

7 Global Espresso Coffee Manufacturers Profiles/Analysis 
7.1 Luigi Lavazza S.p.A. 
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.1.2 Espresso Coffee Product Category, Application and Specification 
7.1.2.1 Product A 
7.1.2.2 Product B 
7.1.3 Luigi Lavazza S.p.A. Espresso Coffee Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.1.4 Main Business/Business Overview 
7.2 Tchibo 
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.2.2 Espresso Coffee Product Category, Application and Specification 
7.2.2.1 Product A 
7.2.2.2 Product B 
7.2.3 Tchibo Espresso Coffee Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.2.4 Main Business/Business Overview 
7.3 Segafredo Zanetti (Massimo Zanetti Beverage Group) 
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.3.2 Espresso Coffee Product Category, Application and Specification 
7.3.2.1 Product A 
7.3.2.2 Product B 
7.3.3 Segafredo Zanetti (Massimo Zanetti Beverage Group) Espresso Coffee Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.3.4 Main Business/Business Overview 
7.4 Bristot (Procaffé S.p.A) 
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.4.2 Espresso Coffee Product Category, Application and Specification 
7.4.2.1 Product A 
7.4.2.2 Product B 
7.4.3 Bristot (Procaffé S.p.A) Espresso Coffee Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.4.4 Main Business/Business Overview 
7.5 illy 
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.5.2 Espresso Coffee Product Category, Application and Specification 
7.5.2.1 Product A 
7.5.2.2 Product B 
7.5.3 illy Espresso Coffee Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.5.4 Main Business/Business Overview 

 

 Continued…….                                                      

Contact Info:
Name: Norah Trent
Email: Send Email
Organization: Wiseguyreports
Address: Office No. 528/524, Amanora Chambers, Magarpatta Road, Hadapsar Pune, Maharashtra 411028
Phone: +1 (339) 368 6938 (US) +44 208 133 9349 (UK)
Website: https://www.wiseguyreports.com

Source URL: https://marketersmedia.com/global-espresso-coffee-market-2019-key-players-share-trends-sales-segmentation-and-forecast-to-2025/506948

Source: MarketersMedia

Release ID: 506948

Global Factoring Market 2019-2025 Analysis by Financial Process, Modern Forms, Specialized Factoring, Risks & Benefits, Company Profiles & Business Opportunities

Factoring is a financial alternative, in financing & management of account receivables. The latest report published by Adroit Market Research provides insights into factoring market by size, share, types, process & global forecast.

Dallas, United States – April 26, 2019 /MarketersMedia/

Emerging economies are in the need of financial support which can be addressed by implementing an improving factoring process more efficiently. Banks can collaborate with technology companies to come up with new solutions that can help in reducing the overall cost of the process. Moreover, Fintech companies are investing in factoring models to improve their efficiency. The aim of Fintech is to make Factoring digital, easy and transparent.

Global Factoring Market is projected to reach USD 9,275.15 billion by 2025. Growing awareness, technological advancement, need for financing, efficiency in process of receiving payment for invoices, increasing trade activities between countries and growing small and medium enterprises are some of the major factors due to which the demand for factoring is expected to grow during the forecast period. The global market is fragmented with the presence of many established international and domestic players.

Get more insights at: Global Factoring Market 2019-2025

The factors such as fess, price, process, eligibility, number of days an invoice can be overdue and maximum amount a company factor monthly based on which one can evaluate and differentiate among factoring companies. Domestic factoring segment had the highest revenue share in 2017 and will continue to dominate in the forecast period owing to its growing popularity in both developed as well as developing nations. However, the international factoring market segment is expected to grow with the highest growth rate owing to its rising number of applications and awareness among export-import businesses. The international factoring market is poised to grow at a growth rate of 15.8% during the period 2018 to 2025.

The growth in international factoring has been mainly driven by the rise in open account trade, specifically from suppliers in the developing countries. The major importers in the developed countries are pushing the demand, including the acceptance of factoring as an appropriate alternative to traditional forms of trade finance. China has played the most important role in this impressive international factoring growth over the past decade, growing at a rate of above 50% per annum, and becoming one of the largest factoring markets globally.

Browse more detail information at: https://www.adroitmarketresearch.com/industry-reports/factoring-market

The Global Factoring Market is fragmented with a large number of domestic and international players. There are around more than 7,000 banks and technology companies that provide factoring services globally. Each region has a list of top players which covers the majority of the market by offering its services. Moreover, banks are integrating with technology to improve efficiency in the process of factoring. Blockchain, the latest technology is also being implemented in this service which is further enhancing the process of factoring by reducing the overall cost and increasing the profit margins. For instance, American International Group collaborated with TradeIX, an open platform for trade finance implemented blockchain in the factoring process.

Some Key Highlight Points from TOC:
Chapter 1. Executive Summary
Chapter 2. Scope of the Report
Chapter 3. Research Methodology
Chapter 4. Market Landscape
Chapter 5. Market Sizing
Chapter 6. Porters Five Forces Analysis
Chapter 7. Customer Landscape
Chapter 8. Market Segmentation by Type
Chapter 9. Regional Landscape
Chapter 10. Company Profiles

For Any Query on the Factoring Market:
https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/837

About US:

Adroit Market Research is an India-based business analytics and consulting company. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.

Contact Info:
Name: Ryan Johnson
Email: Send Email
Organization: Adroit Market Research
Address: 3131 McKinney Ave Ste 600, Dallas, TX 75204, U.S.A
Phone: +1 (214) 884-6068
Website: https://www.adroitmarketresearch.com/industry-reports/factoring-market

Source URL: https://marketersmedia.com/global-factoring-market-2019-2025-analysis-by-financial-process-modern-forms-specialized-factoring-risks-benefits-company-profiles-business-opportunities/506952

Source: MarketersMedia

Release ID: 506952

Preclinical CRO Global Market Requirements, Growth, Future Opportunities, Top Key Players and Forecast to 2025

WiseGuyRerports.com Presents “Global Preclinical CRO Market Research Report 2018” New Document to its Studies Database

Pune, India – April 26, 2019 /MarketersMedia/

This report studies the global Preclinical CRO market status and forecast, categorizes the global Preclinical CRO market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

The global Preclinical CRO market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.

The major manufacturers covered in this report 
Envigo Corporation 
MPI research 
Eurofins Scientific 
PRA Health Sciences, Inc 
Wuxi AppTec 
Medpace, Inc. 
Pharmaceutical Product Development (PPD), LLC 
PARAXEL International Corporation 
ICON Plc. 
Laboratory Corporation of America, Inc.

 Request For Sample Report @ https://www.wiseguyreports.com/sample-request/3285052-global-preclinical-cro-market-research-report-2018                        

                                     

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering 
North America 
Europe 
China 
Japan 
Southeast Asia 
India

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into 
Bioanalysis & DMPK Studies 
Toxicology Testing 
Other Preclinical Services 
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including 
Biopharmaceutical Companies 
Government and Academic Institutes 
Medical Device Companies

The study objectives of this report are: 
To analyze and study the global Preclinical CRO sales, value, status (2013-2017) and forecast (2018-2025). 
Focuses on the key Preclinical CRO manufacturers, to study the sales, value, market share and development plans in future. 
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis. 
To define, describe and forecast the market by type, application and region. 
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. 
To identify significant trends and factors driving or inhibiting the market growth. 
To analyze the opportunities in the market for stakeholders by identifying the high growth segments. 
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market 
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market 
To strategically profile the key players and comprehensively analyze their growth strategies.

 

Complete Report Details @ https://www.wiseguyreports.com/reports/3285052-global-preclinical-cro-market-research-report-2018                

Table Of Contents:      

1 Preclinical CRO Market Overview 
1.1 Product Overview and Scope of Preclinical CRO 
1.2 Preclinical CRO Segment by Type (Product Category) 
1.2.1 Global Preclinical CRO Production and CAGR (%) Comparison by Type (Product Category)(2013-2025) 
1.2.2 Global Preclinical CRO Production Market Share by Type (Product Category) in 2017 
1.2.3 Bioanalysis & DMPK Studies 
1.2.4 Toxicology Testing 
1.2.5 Other Preclinical Services 
1.3 Global Preclinical CRO Segment by Application 
1.3.1 Preclinical CRO Consumption (Sales) Comparison by Application (2013-2025) 
1.3.2 Biopharmaceutical Companies 
1.3.3 Government and Academic Institutes 
1.3.4 Medical Device Companies 
1.4 Global Preclinical CRO Market by Region (2013-2025) 
1.4.1 Global Preclinical CRO Market Size (Value) and CAGR (%) Comparison by Region (2013-2025) 
1.4.2 North America Status and Prospect (2013-2025) 
1.4.3 Europe Status and Prospect (2013-2025) 
1.4.4 China Status and Prospect (2013-2025) 
1.4.5 Japan Status and Prospect (2013-2025) 
1.4.6 Southeast Asia Status and Prospect (2013-2025) 
1.4.7 India Status and Prospect (2013-2025) 
1.5 Global Market Size (Value) of Preclinical CRO (2013-2025) 
1.5.1 Global Preclinical CRO Revenue Status and Outlook (2013-2025) 
1.5.2 Global Preclinical CRO Capacity, Production Status and Outlook (2013-2025)

2 Global Preclinical CRO Market Competition by Manufacturers 
2.1 Global Preclinical CRO Capacity, Production and Share by Manufacturers (2013-2018) 
2.1.1 Global Preclinical CRO Capacity and Share by Manufacturers (2013-2018) 
2.1.2 Global Preclinical CRO Production and Share by Manufacturers (2013-2018) 
2.2 Global Preclinical CRO Revenue and Share by Manufacturers (2013-2018) 
2.3 Global Preclinical CRO Average Price by Manufacturers (2013-2018) 
2.4 Manufacturers Preclinical CRO Manufacturing Base Distribution, Sales Area and Product Type 
2.5 Preclinical CRO Market Competitive Situation and Trends 
2.5.1 Preclinical CRO Market Concentration Rate 
2.5.2 Preclinical CRO Market Share of Top 3 and Top 5 Manufacturers 
2.5.3 Mergers & Acquisitions, Expansion

….

7 Global Preclinical CRO Manufacturers Profiles/Analysis 
7.1 Envigo Corporation 
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.1.2 Preclinical CRO Product Category, Application and Specification 
7.1.2.1 Product A 
7.1.2.2 Product B 
7.1.3 Envigo Corporation Preclinical CRO Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.1.4 Main Business/Business Overview 
7.2 MPI research 
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.2.2 Preclinical CRO Product Category, Application and Specification 
7.2.2.1 Product A 
7.2.2.2 Product B 
7.2.3 MPI research Preclinical CRO Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.2.4 Main Business/Business Overview 
7.3 Eurofins Scientific 
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.3.2 Preclinical CRO Product Category, Application and Specification 
7.3.2.1 Product A 
7.3.2.2 Product B 
7.3.3 Eurofins Scientific Preclinical CRO Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.3.4 Main Business/Business Overview 
7.4 PRA Health Sciences, Inc 
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.4.2 Preclinical CRO Product Category, Application and Specification 
7.4.2.1 Product A 
7.4.2.2 Product B 
7.4.3 PRA Health Sciences, Inc Preclinical CRO Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.4.4 Main Business/Business Overview 
7.5 Wuxi AppTec 
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.5.2 Preclinical CRO Product Category, Application and Specification 
7.5.2.1 Product A 
7.5.2.2 Product B 
7.5.3 Wuxi AppTec Preclinical CRO Capacity, Production, Revenue, Price and Gross Margin (2015-2018) 
7.5.4 Main Business/Business Overview 

 

 Continued…….                                                      

Contact Info:
Name: Norah Trent
Email: Send Email
Organization: Wiseguyreports
Address: Office No. 528/524, Amanora Chambers, Magarpatta Road, Hadapsar Pune, Maharashtra 411028
Phone: +1 (339) 368 6938 (US) +44 208 133 9349 (UK)
Website: https://www.wiseguyreports.com

Source URL: https://marketersmedia.com/preclinical-cro-global-market-requirements-growth-future-opportunities-top-key-players-and-forecast-to-2025/506950

Source: MarketersMedia

Release ID: 506950